Exploring the Future of Cyclic Peptide Therapeutics with Viva Biotech
Exploring the Future of Cyclic Peptide Therapeutics with Viva Biotech
Peptides have recently taken center stage in the world of therapeutic innovation, particularly cyclic peptides, because of their unique ability to effectively bridge the gap between small molecules and larger biologics. Positioned neatly between the two categories, cyclic peptides offer the oral bioavailability of small molecules while also harnessing the structural advantages that biologics provide. This combination makes them uniquely suited to interact with traditionally